Ignite Creation Date:
2024-05-06 @ 3:15 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02241525
Status:
TERMINATED
Last Update Posted:
2020-03-18
First Post:
2014-08-29
Brief Title:
CT for Pulmonary Thromboembolic Disease
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Individually Optimized Uniform Contrast Enhancement in CT Angiography for the Diagnosis of Pulmonary Thromboembolic Disease
Status:
TERMINATED
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The PI left the university
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CT for PE
Brief Summary:
Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography CTPA for the diagnosis of pulmonary thromboembolic disease
Detailed Description:
Patient characteristics qualitative image quality scores and quantitative contrast enhancement and CNR will be described using mean values and standard deviations for continuous variables and frequencies and percent for categorical variables Difference between the two patient groups will be compared using Wilcoxon signed rank tests and chi-square statistics for continuous and categorical variables respectively All statistical tests will be performed at a significance level of 005
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None